Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -9,850 | 66 | N/A | N/A |
| Depreciation Amortization | 367 | 385 | N/A | N/A |
| Accounts receivable | 465 | -338 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,116 | -549 | N/A | N/A |
| Other Working Capital | 593 | -3,942 | N/A | N/A |
| Other Operating Activity | 2,243 | 1,301 | 0 | 0 |
| Operating Cash Flow | $-5,066 | $-3,077 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -267 | -50 | N/A | N/A |
| Investing Cash Flow | $-267 | $-50 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,210 | 327 | N/A | N/A |
| Debt Repayment | -182 | N/A | N/A | N/A |
| Common Stock Issued | 11,963 | N/A | N/A | N/A |
| Other Financing Activity | 7,342 | 0 | 0 | 0 |
| Financing Cash Flow | $20,334 | $327 | $N/A | $N/A |
| Exchange Rate Effect | -216 | 161 | N/A | N/A |
| Beginning Cash Position | 3,689 | 6,327 | N/A | N/A |
| End Cash Position | 18,474 | 3,689 | N/A | N/A |
| Net Cash Flow | $14,785 | $-2,638 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,066 | -3,077 | N/A | N/A |
| Capital Expenditure | -267 | -50 | N/A | N/A |
| Free Cash Flow | -5,333 | -3,126 | 0 | 0 |